Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and commercialization of technologies and products to address medication abuse and misuse. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. The company has six additional opioid products in various stages of formulation development. Acura Pharmaceuticals, Inc. has collaboration and license agreements with Egalet US, Inc.; and Egalet Ltd. to manufacture and commercialize Oxaydo products worldwide. The company was founded in 1935 and is based in Palatine, Illinois.
Industry, Sector and Symbol
Industry Pharmaceutical preparations
Sub-IndustryPharmaceuticals
SectorMedical
Phone847-705-7709
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$2.97 million
Profitability
Miscellaneous
Employees14
OptionableNot Optionable
Acura Pharmaceuticals (OTCMKTS:ACUR) Frequently Asked Questions
What is Acura Pharmaceuticals' stock symbol?
Acura Pharmaceuticals trades on the OTCMKTS under the ticker symbol "ACUR."
How were Acura Pharmaceuticals' earnings last quarter?
Acura Pharmaceuticals, Inc. (OTCMKTS:ACUR) announced its quarterly earnings data on Tuesday, November, 27th. The specialty pharmaceutical company reported ($0.05) earnings per share for the quarter. The specialty pharmaceutical company earned $0.07 million during the quarter. View Acura Pharmaceuticals' Earnings History.
When is Acura Pharmaceuticals' next earnings date?
What price target have analysts set for ACUR?
0 brokerages have issued 1-year target prices for Acura Pharmaceuticals' shares. Their predictions range from $0.55 to $0.55. On average, they expect Acura Pharmaceuticals' stock price to reach $0.55 in the next year. This suggests a possible upside of 236.4% from the stock's current price. View Analyst Price Targets for Acura Pharmaceuticals.
Has Acura Pharmaceuticals been receiving favorable news coverage?
News articles about ACUR stock have trended extremely positive on Saturday, InfoTrie Sentiment Analysis reports. The research firm rates the sentiment of press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Acura Pharmaceuticals earned a coverage optimism score of 4.3 on InfoTrie's scale. They also assigned news coverage about the specialty pharmaceutical company a news buzz of 2.0 out of 10, indicating that recent press coverage is very unlikely to have an impact on the company's share price in the near term.
Who are some of Acura Pharmaceuticals' key competitors?
Some companies that are related to Acura Pharmaceuticals include International Stem Cell (ISCO), ERBA Diagnostics (ERBA), DelMar Pharmaceuticals (DMPI), Wellness Center USA (WCUI), MusclePharm (MSLP), Uluru (ULUR), Dare Bioscience (DARE), X T L Biopharmaceuticals (XTLB), NeuroVive Pharmaceutical (NEVPF), Cyclacel Pharmaceuticals (CYCC), Cellectar Biosciences (CLRB), Regulus Therapeutics (RGLS), Vital Therapies (VTL), Peak Pharmaceuticals (PKPH) and Aytu Bioscience (AYTU).
Who are Acura Pharmaceuticals' key executives?
Acura Pharmaceuticals' management team includes the folowing people:
- Mr. Robert B. Jones, CEO, Pres & Director (Age 60)
- Mr. Peter A. Clemens, Sr. VP, CFO & Sec. (Age 66)
- Dr. Albert W. Brzeczko, VP of Technical Affairs (Age 62)
- Mr. James F. Emigh, VP of Corp. Devel. (Age 63)
- Mr. Robert A. Seiser Ph.D., VP, Treasurer & Corp. Controller (Age 55)
How do I buy shares of Acura Pharmaceuticals?
Shares of ACUR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Acura Pharmaceuticals' stock price today?
One share of ACUR stock can currently be purchased for approximately $0.1635.
How big of a company is Acura Pharmaceuticals?
Acura Pharmaceuticals has a market capitalization of $2.79 million and generates $2.97 million in revenue each year. Acura Pharmaceuticals employs 14 workers across the globe.
What is Acura Pharmaceuticals' official website?
How can I contact Acura Pharmaceuticals?
Acura Pharmaceuticals' mailing address is 616 N. NORTH COURT SUITE 120, PALATINE IL, 60067. The specialty pharmaceutical company can be reached via phone at 847-705-7709 or via email at [email protected]
MarketBeat Community Rating for Acura Pharmaceuticals (OTCMKTS ACUR)
MarketBeat's community ratings are surveys of what our community members think about Acura Pharmaceuticals and other stocks. Vote "Outperform" if you believe ACUR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ACUR will underperform the S&P 500 over the long term. You may vote once every thirty days.
